Jacobs Levy Equity Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$111K Buy
+36,888
New +$150K ﹤0.01% 891
2024
Q4
– Sell
-3,683
Closed -$37.4K – 1018
2024
Q3
$37.4K Sell
3,683
-22,731
-86% -$676K ﹤0.01% 941
2024
Q2
$1.53M Sell
26,414
-120
-0.5% -$5.88K 0.01% 653
2024
Q1
$884K Buy
26,534
+6,084
+30% +$308K ﹤0.01% 737
2023
Q4
$1.66M Buy
+20,450
New +$1.66M 0.01% 638

Other funds holding OM

Jacobs Levy Equity Management's OM Position: Q3 2026 in Review

Jacobs Levy Equity Management opened a new position in Outset Medical (OM) in Q3 2026: 36,888 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #891 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in OM as recently as Q3 2024.

Jacobs Levy Equity Management first reported a position in OM in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.66M in Q4 2023. 77 funds tracked by Wall St. Rank hold OM as of Q3 2026.

  • Jacobs Levy Equity Management held 36,888 shares of Outset Medical worth $111K as of Q3 2026.
  • Outset Medical was a new Jacobs Levy Equity Management position in Q3 2026.
  • Outset Medical made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q3 2026, its #891 holding.
  • Jacobs Levy Equity Management first reported a position in Outset Medical in Q4 2023 and has held it in 5 quarters since.
  • Jacobs Levy Equity Management's Outset Medical position peaked at $1.66M in Q4 2023.
  • 77 funds tracked by Wall St. Rank held Outset Medical as of Q3 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.